| Literature DB >> 34702909 |
Régis Radaelli1, Dennis R Taaffe2,3, Robert U Newton2,3,4, Daniel A Galvão2,3, Pedro Lopez5,6.
Abstract
To systematically review and analyse the effects of exercise on morphological and neuromuscular muscle quality (MQ) outcomes in older adults and assess a range of possible moderators that may affect the impact of exercise on MQ outcomes. Using PRISMA guidelines, randomised controlled trials were searched in CINAHL, EMBASE, LILACS, PubMed, SciELO, Web of Science, MedNar, OpenGrey and OpenThesis databases. Eligible trials examined the effects of exercise interventions on morphological and neuromuscular MQ in older adults (≥ 60 years). Twenty-one trials (n = 973 participants) were included. Exercise significantly improved morphological MQ (effect size (ES) = 0.32, 95% CI 0.13-0.51, P < 0.001) with significant results maintained for studies assessing muscle density and intermuscular adipose tissue (ES = 0.45-0.52, P < 0.05). For neuromuscular MQ, exercise provided significant positive effects (ES = 0.49, 95% CI 0.29-0.69, P < 0.001) but only maintained for physically healthy participants (ES = 0.43, P < 0.001), resistance exercise interventions (ES = 0.64, P < 0.001), or studies assessing 1-RM or knee extensor isokinetic muscle strength relative to leg lean mass (ES = 0.48-0.62, P = 0.001). Associations between exercise duration and changes in MQ measures were not observed (P > 0.05). Supervised exercise interventions significantly improved different measures of MQ regardless of exercise duration, although these effects were small-to-moderate and not supported across all population-, exercise-, and methods-related features.Entities:
Mesh:
Year: 2021 PMID: 34702909 PMCID: PMC8548567 DOI: 10.1038/s41598-021-00600-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow chart of study selection process.
Risk of bias of included studies.
| Outcome | Randomisation process | Deviation from intended interventions | Missing outcome data | Measurement of the outcome | Selection of the reported result | Overall bias |
|---|---|---|---|---|---|---|
| Low risk | 2 (18.2%) | 11 (100%) | 10 (90.9%) | 9 (81.8%) | 11 (100%) | 2 (18.2%) |
| Some concerns | 8 (72.7%) | 0 | 0 | 0 | 0 | 6 (54.5%) |
| High risk | 1 (9.1%) | 0 | 1 (9.1%) | 2 (18.2%) | 0 | 3 (27.3%) |
| Low risk | 1 (7.1%) | 14 (100%) | 13 (92.9%) | 8 (57.1%) | 14 (100%) | 1 (7.1%) |
| Some concerns | 8 (57.1%) | 0 | 0 | 0 | 0 | 5 (35.7%) |
| High risk | 5 (35.7%) | 0 | 1 (7.1%) | 6 (42.9%) | 0 | 8 (57.1%) |
MQ, muscle quality; n, number of studies.
aIntention-to-treat analyses, n = 8 and per-protocol analyses, n = 3.
bIntention-to-treat analyses, n = 5 and per-protocol analyses, n = 9.
Overall and subgroup exercise effects on MQ derived from morphological outcomes in older adults.
| Main effects | n | Sample size | SMD (95% CI) | I2 | P-value |
|---|---|---|---|---|---|
| Overall effect | 11 | 472 | 0.23 (− 0.01 to 0.48) | 52% | 0.062 |
| Without outlier | 10 | 387 | 0.32 (0.13 to 0.51) | 3% | < 0.001 |
| Low risk of bias | 2 | 109 | − 0.26 (− 0.57 to 0.05) | 3% | 0.104 |
| Some concerns or high risk of bias | 9 | 363 | 0.33 (0.13 to 0.05) | 11% | 0.001 |
| Physically healthy | 7 | 295 | 0.08 (− 0.20 to 0.36) | 38% | 0.586 |
| Sarcopenia/dynapenia† | 1 | 84 | 0.23 (− 0.22 to 0.69) | – | – |
| Moderate limited functional capacity† | 1 | 42 | 0.40 (− 0.06 to 0.86) | – | – |
| Overweight/obese† | 1 | 27 | 1.01 (0.40 to 1.62) | – | – |
| Frail† | 1 | 24 | 0.20 (− 0.40 to 0.80) | – | – |
| Supervised | 11 | 472 | 0.23 (− 0.01 to 0.48) | 52% | 0.062 |
| Unsupervised | - | - | − | – | – |
| Resistance exercise | 6 | 196 | 0.34 (− 0.13 to 0.81) | 65% | 0.161 |
| Resistance exercise + nutrition† | 1 | 56 | 0.55 (0.01 to 1.09) | – | – |
| Aerobic exercise | 2 | 55 | 0.18 (− 0.27 to 0.62) | 0% | 0.443 |
| Combined resistance and aerobic exercise† | 1 | 36 | 0.36 (− 0.32 to 1.05) | – | – |
| Multimodal exercise program | 3 | 151 | 0.06 (− 0.43 to 0.55) | 72% | 0.812 |
| Aquatic resistance exercise† | 1 | 36 | 0.25 (− 0.40 to 0.90) | – | – |
| Muscle density† | 1 | 42 | 0.11 (− 0.49 to 0.72) | – | – |
| High muscle density | 4 | 122 | 0.52 (0.05 to 0.99) | 34% | 0.030 |
| Low muscle density | 3 | 80 | 0.34 (− 0.16 to 0.83) | 19% | 0.186 |
| Intermuscular adipose tissue | 3 | 98 | 0.45 (0.05 to 0.86) | 0% | 0.027 |
| Echo intensity | 3 | 146 | 0.21 (− 0.12 to 0.55) | 0% | 0.220 |
| Muscle density | 2 | 138 | − 0.18 (− 0.61 to 0.23) | 32% | 0.377 |
| Intermuscular adipose tissue† | 1 | 85 | − 0.28 (− 0.71 to 0.14) | – | – |
| Echo intensity† | 1 | 24 | 0.12 (− 0.68 to 0.92) | – | – |
†Insufficient data for analysis; I2, indicator of between-study heterogeneity; n, number of studies; SMD, standardised mean difference.
Figure 2Standardised mean difference effects of exercise compared with control on morphological muscle quality outcomes in older adults. Overall analysis conducted with a random-effects model. Diamond represents pooled standardised mean difference estimate of random-effects meta-analysis; I2 represents the heterogeneity test; MQ, muscle quality; squares represent study-specific estimates.
Figure 3Standardised mean difference effects of exercise compared with control on neuromuscular muscle quality outcomes in older adults. Overall analysis conducted with a random-effects model. Diamond represents pooled standardised mean difference estimate of random-effects meta-analysis; I2 represents the heterogeneity test; MQ, muscle quality; squares represent study-specific estimates.
Overall and subgroup exercise effects on MQ derived from neuromuscular outcomes in older adults.
| Main effects | n | Sample size | SMD (95% CI) | I2 | P-value |
|---|---|---|---|---|---|
| Overall effect | 14 | 538 | 0.59 (0.33 to 0.85) | 51% | < 0.001 |
| Without outlier | 13 | 482 | 0.49 (0.29 to 0.69) | 11% | < 0.001 |
| Low risk of bias† | 1 | 24 | 0.30 (− 1.11 to 0.51) | – | – |
| Some concerns or high risk of bias | 13 | 514 | 0.64 (0.39 to 0.89) | 45% | < 0.001 |
| Physically healthy | 10 | 367 | 0.43 (0.21 to 0.64) | 0% | < 0.001 |
| Overweight/ Obese | 2 | 73 | 0.79 (− 0.10 to 1.68) | 67% | 0.082 |
| Moderate functional capacity† | 1 | 42 | 0.72 (0.10 to 1.35) | – | – |
| Sarcopenic obesity† | 1 | 56 | 1.69 (1.07 to 2.32) | – | – |
| Supervised | 13 | 492 | 0.61 (0.33 to 0.89) | 54% | < 0.001 |
| Unsupervised | – | – | − | – | – |
| Resistance exercise | 10 | 353 | 0.64 (0.27 to 1.01) | 63% | < 0.001 |
| Resistance exercise + nutrition† | 1 | 28 | 0.44 (− 0.32 to 1.20) | – | – |
| Aerobic exercise† | 1 | 22 | 0.19 (− 0.65 to 1.03) | – | – |
| Aerobic exercise + nutrition† | 1 | 21 | 0.57 (− 0.31 to 1.45) | – | – |
| Combined resistance and aerobic exercise† | 1 | 49 | 0.33 (− 0.24 to 0.91) | – | – |
| Combined resistance and aerobic exercise + caloric restriction† | 1 | 46 | 0.38 (− 0.21 to 0.97) | – | – |
| Multimodal exercise program† | 1 | 42 | 0.72 (0.10 to 1.35) | – | – |
| 1-RM/DXA | 3 | 111 | 0.65 (0.26 to 1.05) | 0% | 0.001 |
| 1-RM/CT† | 1 | 27 | 1.30 (0.45 to 2.14) | – | – |
| 1-RM/US† | 1 | 36 | 0.07 (− 0.58 to 0.72) | – | – |
| Isokinetic/DXA | 5 | 195 | 0.48 (0.19 to 0.78) | 0% | 0.001 |
| Isokinetic/CT | 2 | 91 | 0.42 (− 0.16 to 0.99) | 46% | 0.155 |
| Isometric/DXA† | 1 | 56 | 1.69 (1.07 to 2.32) | – | – |
| Isometric/CT† | 1 | 49 | 0.30 (− 0.27 to 0.87) | – | – |
| Isometric/BIA† | 1 | 36 | 0.09 (− 0.58 to 0.76) | – | – |
| 30° sec−1/US† | 1 | 24 | − 0.46 (− 1.27 to 0.35) | – | – |
| Isometric/US† | 1 | 24 | 0.00 (− 0.80 to 0.80) | – | – |
†Insufficient data for analysis, BIA, Bioelectrical impedance analysis; CT, computed tomography; DXA, dual-energy X-ray absorptiometry; I2, indicator of between-study heterogeneity; n, number of studies; SMD, standardised mean difference; US, muscle ultrasound.